Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.59% | $165.65M | €460.22B | 65.75% | 76 Outperform | |
| Roche Holding AG | 1.46% | $93.70M | CHF282.72B | 43.82% | 73 Outperform | |
| HSBC Holdings | 1.44% | $91.90M | £226.51B | 49.15% | 80 Outperform | |
| AstraZeneca | 1.36% | $87.07M | £215.33B | 21.85% | 80 Outperform | |
| Novartis AG | 1.34% | $85.93M | CHF228.77B | 23.72% | 80 Outperform | |
| Toyota Motor | 1.29% | $82.36M | ¥48.60T | 32.64% | 80 Outperform | |
| Nestlé SA | 1.21% | $77.70M | CHF198.27B | 20.08% | 71 Outperform | |
| Siemens | 1.04% | $66.55M | €199.71B | 20.73% | 74 Outperform | |
| Shell (UK) | 1.03% | $66.04M | £159.79B | 4.91% | 73 Outperform | |
| Mitsubishi UFJ Financial Group | 1.01% | $64.77M | ¥33.07T | 56.53% | 76 Outperform |